FindTrial
Sign In

The use of virtual reality and exposure therapy for the treatment of methamphetamine use disorder

A research for virtual reality and exposure therapy decreasing cue reactivity and relapse of methamphetamine use disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020014
Enrollment
Unknown
Registered
2018-12-11
Start date
2018-12-24
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

substance related disorders

Interventions

Group1:Virtual reality combining with classical cue exposure therapy
Group2:Virtual reality combining with complex cue exposure therapy
Group3:Virtual reality without other intervention methods

Sponsors

the second Xiangya hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 2-6 months prior to be out of the Drug Rehabilitation Center;Meet DSM-5 diagnostic criteria for stimulant use disorders; 2. Users of methamphetamine; 3. 18-55 years old;Normal vision or corrected vision;Primary school education or above; 4. Be able to and willing to provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. multi-drugs abuse 2. A history of mental illness or family history of mental illness;Serious physical diseases, physical disabilities, such as blindness. 3. Major medical diseases requiring regular drug treatment; 4. With serious physical disease or obvious mental disorder; with obvious drug reaction.

Design outcomes

Primary

MeasureTime frame
subject craving;pulse;Electroencephalogram;attention behaviour;—

Countries

China

Contacts

Public ContactChen Hongxian

the second Xiangya hospital of Central South University

Shenhx2018@csu.edu.cn+86 13875970393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026